Ads
related to: Psoriatic Arthritis Medicine- PsO & Psoriatic Arthritis
Learn More About The Connection
& View Patient Resources.
- Register For Savings
Sign Up For Information, Updates,
& A $0 Co-Pay Savings Offer.
- The PsO & PsA Connection
See The Signs & Symptoms Of PsA
To Look Out For If You Have PsO.
- Clinical Trial Results
Get The Facts On How Treatment
Performed In Clinical Trials Here.
- Plaque Psoriasis In Kids
See A Treatment Option
For Children 6 Years & Older.
- Discussion Guide
Questions To Ask Before Seeing Your
Doctor To Talk About Treatment.
- PsO & Psoriatic Arthritis
Search results
Galapagos (NASDAQ:GLPG) Reaches New 52-Week Low at $29.45
ETF DAILY NEWS· 7 days agoShares of Galapagos NV (NASDAQ:GLPG – Get Free Report) reached a new 52-week low on Tuesday . The company traded as low as $29.45 and last traded at $29.49, with a volume of 16106 shares. The ...
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant...
NBC 17 Raleigh· 7 days ago− Results from the Phase 3 SELECT-GCA study showed 46 percent of patients with giant cell arteritis (GCA) who were treated with upadacitinib (RINVOQ®; 15 mg) with a 26-week steroid taper regimen ...
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed...
Benzinga· 21 hours agoThe confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® (golimumab), met its primary endpoint in patients with moderate to severe rheumatoid
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 2 days agoSource: Takeda Pharmaceutical. Conclusion Takeda is one of the leaders in the global gastrointestinal and cancer therapeutics markets, which is...
YHB Investment Advisors Inc. Trims Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 6 days agoYHB Investment Advisors Inc. reduced its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 6.7% during the 4th quarter, according to its most recent 13F filing with the Securities ...
Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening...
Morningstar· 3 days agoAd hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Pyzchiva® approved as one of first ustekinumab biosimilars in EuropeEC approval based on robust development program confirming ...
Wealthspan Partners LLC Raises Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 7 days agoWealthspan Partners LLC boosted its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 6.0% during the fourth quarter, according to its most recent disclosure with the Securities and ...
Tufton Capital Management Trims Stock Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 19 hours agoTufton Capital Management decreased its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the ...
Ads
related to: Psoriatic Arthritis Medicine